Best Practice & Research Clinical Haematology
Volume 21, Issue 3 , Pages 543-557, September 2008

Targeting haematopoietic-specific minor histocompatibility antigens to distinguish graft-versus-tumour effects from graft-versus-host disease

  • Robbert Spaapen, MSc (Research Associate in Haematology)
    • ,
  • Tuna Mutis, MD, PhD (Assistant Professor in Haematology)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +31 (0) 88 755 6504; Fax: +31 (0) 88 755 5418.

Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(08)00052-2

doi:10.1016/j.beha.2008.06.001

Best Practice & Research Clinical Haematology
Volume 21, Issue 3 , Pages 543-557, September 2008

Article Tools

* Image Usage & Resolution